Delivery Order SPE2DB22D1017-SPE2DB24FF5SJ
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $10,417.54 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The federal contract award detailed here was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,503.53 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $26,407.59 firm fixed price delivery order is for the supply of Eliquis 5 mg tablet 60s, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
- This federal contract award, valued at $16,230.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The contract is a delivery order that runs through April 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $15,733.66 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. Amerisourcebergen Drug Corp serves as a prime contractor to DLA, holding an indefinite delivery contract (IDC) valued up to $999,999,999.00 through December 2025 to provide a wide range of...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The $19,541.94 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Eliquis 5 mg tablets. The contract, valued at $17,951.80, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Eliquis 5 mg tablets. The $7,018.95 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of July 2, 2024. The contract is not set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $12,224.90 firm fixed-price delivery order is for the supply of 4,564,286 units of the medication Eliquis 5 mg tablet. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The $7,337.79 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5SJDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $12,241.20 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. This delivery order falls under a $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor, and its parent company, Cencora, Inc., doing business as Amerisourcebergen, is also involved in federal contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 4/10/24 |